EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis.

European Association for Study of Liver, Asociacion Latinoamericana para el Estudio del Higado

MeSH — NLM indexing Carcinoma, Hepatocellular / diagnosis Diagnostic Techniques, Digestive System / standards Europe Humans Liver Neoplasms / diagnosis Prognosis Severity of Illness Index

Staff actions

Download PDF

Files are for authorised use within BioPredictive partner channels only.

Key publication Fibrotest Actitest Guideline Independent Group Switzerland

Authors (2)

Citation

European Association for Study of Liver, Asociacion Latinoamericana para el Estudio del Higado. EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol. 2015;63(1):237-64. doi:10.1016/j.jhep.2015.04.006.

Identifiers

DOI: 10.1016/j.jhep.2015.04.006
PMID: 25911335

Tests

Liver diseases

Liver injuries

Comparisons

Subjects

Region

EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis.

More on the same topic

Diagnostic performance of FibroTest-ActiTest, transient elastography, and the fibrosis-4 index in patients with autoimmune hepatitis using histological reference.

Metabolic dysfunction-associated steatotic liver disease (MASLD) biomarkers and progression of lower limb arterial calcification in patients with type 2 diabetes: a prospective cohort study.

Three Neglected STARD Criteria Reduce the Uncertainty of the Liver Fibrosis Biomarker FibroTest-T2D in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

Toward non-invasive assessment strategies in autoimmune hepatitis.

Accuracy of prognostic serological biomarkers in predicting liver fibrosis severity in people with metabolic dysfunction-associated steatotic liver disease: a meta-analysis of over 40,000 participants.

Non-alcoholic fatty liver disease biomarkers estimate cardiovascular risk based on coronary artery calcium score in type 2 diabetes: a cross-sectional study with two independent cohorts.